Esperion and Daiichi Sankyo Europe Announce Amendment to License and Commercial Collaboration Agreement
Esperion to Receive $150 Million Milestone Payment in June Esperion Completes Transfer of Marketing Authorization Approvals (MAAs) for NILEMDO™ (bempedoic acid) […]